← Evidence map

ArticleJCI insight2020

Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.

Qi Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

31 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31935197